218 related articles for article (PubMed ID: 32989144)
21. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
[TBL] [Abstract][Full Text] [Related]
22. Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
Morris SM; Davison J; Carter KT; O'Leary RM; Trobridge P; Knoblaugh SE; Myeroff LL; Markowitz SD; Brett BT; Scheetz TE; Dupuy AJ; Starr TK; Grady WM
Int J Cancer; 2017 Feb; 140(4):853-863. PubMed ID: 27790711
[TBL] [Abstract][Full Text] [Related]
23. Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids.
Fumagalli A; Drost J; Suijkerbuijk SJ; van Boxtel R; de Ligt J; Offerhaus GJ; Begthel H; Beerling E; Tan EH; Sansom OJ; Cuppen E; Clevers H; van Rheenen J
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2357-E2364. PubMed ID: 28270604
[TBL] [Abstract][Full Text] [Related]
24. Organoids Are Limited in Modeling the Colon Adenoma-Carcinoma Sequence.
Tokumaru Y; Oshi M; Patel A; Tian W; Yan L; Matsuhashi N; Futamura M; Yoshida K; Takabe K
Cells; 2021 Feb; 10(3):. PubMed ID: 33668713
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression.
Komor MA; de Wit M; van den Berg J; Martens de Kemp SR; Delis-van Diemen PM; Bolijn AS; Tijssen M; Schelfhorst T; Piersma SR; Chiasserini D; Sanders J; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; Carvalho B; Meijer GA; Jimenez CR; Fijneman RJA;
Int J Cancer; 2020 Apr; 146(7):1979-1992. PubMed ID: 31411736
[TBL] [Abstract][Full Text] [Related]
26. Somatic mutations of the APC, KRAS, and TP53 genes in nonpolypoid colorectal adenomas.
van Wyk R; Slezak P; Hayes VM; Buys CH; Kotze MJ; de Jong G; Rubio C; Dolk A; Jaramillo E; Koizumi K; Grobbelaar JJ
Genes Chromosomes Cancer; 2000 Feb; 27(2):202-8. PubMed ID: 10612810
[TBL] [Abstract][Full Text] [Related]
27. Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis.
Diab-Assaf M; Abou-Khouzam R; Saadallah-Zeidan N; Habib K; Bitar N; Karam W; Liagre B; Harakeh S; Azar R
Int J Clin Exp Pathol; 2015; 8(1):404-13. PubMed ID: 25755728
[TBL] [Abstract][Full Text] [Related]
28. Colon Tumors with the Simultaneous Induction of Driver Mutations in APC, KRAS, and PIK3CA Still Progress through the Adenoma-to-carcinoma Sequence.
Hadac JN; Leystra AA; Paul Olson TJ; Maher ME; Payne SN; Yueh AE; Schwartz AR; Albrecht DM; Clipson L; Pasch CA; Matkowskyj KA; Halberg RB; Deming DA
Cancer Prev Res (Phila); 2015 Oct; 8(10):952-61. PubMed ID: 26276752
[TBL] [Abstract][Full Text] [Related]
29. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
Hilkens J; Timmer NC; Boer M; Ikink GJ; Schewe M; Sacchetti A; Koppens MAJ; Song JY; Bakker ERM
Gut; 2017 Jun; 66(6):1095-1105. PubMed ID: 27511199
[TBL] [Abstract][Full Text] [Related]
30. Wnt and BMP signals control intestinal adenoma cell fates.
Farrall AL; Riemer P; Leushacke M; Sreekumar A; Grimm C; Herrmann BG; Morkel M
Int J Cancer; 2012 Nov; 131(10):2242-52. PubMed ID: 22344573
[TBL] [Abstract][Full Text] [Related]
31. Eukaryotic Initiation Factor 4E (eIF4E) sequestration mediates 4E-BP1 response to rapamycin.
Batool A; Majeed ST; Aashaq S; Majeed R; Shah G; Nazir N; Andrabi KI
Int J Biol Macromol; 2019 Mar; 125():651-659. PubMed ID: 30552925
[TBL] [Abstract][Full Text] [Related]
32. A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer.
Arvai KJ; Hsu YH; Lee LA; Jones D
PLoS One; 2015; 10(6):e0131108. PubMed ID: 26098881
[TBL] [Abstract][Full Text] [Related]
33. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
[TBL] [Abstract][Full Text] [Related]
34. Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells.
Jaeckel S; Kaller M; Jackstadt R; Götz U; Müller S; Boos S; Horst D; Jung P; Hermeking H
Nat Commun; 2018 Sep; 9(1):3573. PubMed ID: 30177706
[TBL] [Abstract][Full Text] [Related]
35. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
36. Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc
Hull MA; Cuthbert RJ; Ko CWS; Scott DJ; Cartwright EJ; Hawcroft G; Perry SL; Ingram N; Carr IM; Markham AF; Bonifer C; Coletta PL
Sci Rep; 2017 Jul; 7(1):6074. PubMed ID: 28729694
[TBL] [Abstract][Full Text] [Related]
37. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic signaling is coupled to colorectal cancer cell differentiation state.
Sell T; Klotz C; Fischer MM; Astaburuaga-García R; Krug S; Drost J; Clevers H; Sers C; Morkel M; Blüthgen N
J Cell Biol; 2023 Jun; 222(6):. PubMed ID: 37017636
[TBL] [Abstract][Full Text] [Related]
39. New insights into 4E-BP1-regulated translation in cancer progression and metastasis.
Wang J; Ye Q; She QB
Cancer Cell Microenviron; 2014; 1(5):. PubMed ID: 26005705
[TBL] [Abstract][Full Text] [Related]
40. Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors.
Li H; Zhang J; Tong JHM; Chan AWH; Yu J; Kang W; To KF
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]